YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis

MLA

Shuai Zhou, et al. “YY1 Activates EMI2 and Promotes the Progression of Cholangiocarcinoma through the PI3K/Akt Signaling Axis.” Cancer Cell International, vol. 21, no. 1, Dec. 2021, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s12935-021-02328-6.

APA

Shuai Zhou, Kang Lin Qu, Jin Ang Li, Shi Lei Chen, Yi Gang Zhang, Chao Zhu, Hao Jin, Yong Wang, Qing Pang, & Hui Chun Liu. (2021). YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis. Cancer Cell International, 21(1), 1–16. https://doi.org/10.1186/s12935-021-02328-6

Chicago

Shuai Zhou, Kang Lin Qu, Jin Ang Li, Shi Lei Chen, Yi Gang Zhang, Chao Zhu, Hao Jin, Yong Wang, Qing Pang, and Hui Chun Liu. 2021. “YY1 Activates EMI2 and Promotes the Progression of Cholangiocarcinoma through the PI3K/Akt Signaling Axis.” Cancer Cell International 21 (1): 1–16. doi:10.1186/s12935-021-02328-6.